Literature DB >> 6199473

Fertility after chemotherapy for testicular cancer.

R E Drasga, L H Einhorn, S D Williams, D N Patel, E E Stevens.   

Abstract

Sixty-nine patients with disseminated testicular cancer and no prior retroperitoneal lymphadenectomy treated with cisplatin, vinblastine, and bleomycin with or without doxorubicin were evaluated for semen analysis, serum gonadotropins, and testosterone. Since 1979, 41 men have been prospectively studied. Before treatment 77% were oligospermic, 17% were azoospermic, and only 6.6% could meet requirements for sperm banking. After 2 mo of therapy, 96% were azoospermic. A group of 28 patients treated between 1975 and 1979 were retrospectively evaluated. Normal sperm counts were found in 46% of those studied. Only 17% were azoospermic. Thirty-two percent have impregnated their wives, resulting in 5 healthy babies, 1 spontaneous abortion, and 3 ongoing pregnancies. These results show that (1) significant impairment of spermatogenesis exists before therapy, precluding the possibility of sperm banking in most patients, (2) combination chemotherapy in testicular cancer has substantial effects on gonadal function, rendering almost all patients azoospermic, and (3) a high degree of recovery of spermatogenesis occurs sometime after 2-3 yr from the initiation of treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6199473     DOI: 10.1200/JCO.1983.1.3.179

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  28 in total

Review 1.  Comparative tolerability of chemotherapy regimens for germ cell cancer.

Authors:  S Culine; J P Droz
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Effects of cancer and anti-neoplastic treatment on the human testicular function.

Authors:  A De Palma; E Vicari; I Palermo; R D'Agata; A E Calogero
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

3.  Congruence of reproductive concerns among adolescents with cancer and parents: pilot testing an adapted instrument.

Authors:  Gwendolyn P Quinn; Caprice Knapp; Devin Murphy; Kelly Sawczyn; Leonard Sender
Journal:  Pediatrics       Date:  2012-03-19       Impact factor: 7.124

4.  Impact of temozolomide on gonadal function in patients with primary malignant brain tumors.

Authors:  R E Strowd; R Blackwood; M Brown; M Harmon; J Lovato; T Yalcinkaya; G Lesser
Journal:  J Oncol Pharm Pract       Date:  2013-01-04       Impact factor: 1.809

5.  Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors.

Authors:  J Baniel; B J Roth; R S Foster; J P Donohue
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

6.  Cancer, chemotherapy, and fertility.

Authors:  J Waxman
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-13

7.  Testicular cancer and the legacy of chemotherapy.

Authors:  F M Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 8.  Anticancer chemotherapeutic agents and testicular dysfunction.

Authors:  Kohei Yamaguchi; Masato Fujisawa
Journal:  Reprod Med Biol       Date:  2011-03-17

9.  Fertility among testicular cancer survivors: a case-control study in the U.S.

Authors:  Christopher Kim; Katherine A McGlynn; Ruth McCorkle; Tongzhang Zheng; Ralph L Erickson; David W Niebuhr; Shuangge Ma; Yaqun Zhang; Yana Bai; Li Dai; Barry I Graubard; Briseis Kilfoy; Kathryn Hughes Barry; Yawei Zhang
Journal:  J Cancer Surviv       Date:  2010-06-23       Impact factor: 4.442

10.  The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.

Authors:  Irene A Burger; Hebert Alberto Vargas; Debra A Goldman; Mithat Gonen; Anita Kumar; Andrew D Zelenetz; Heiko Schöder; Hedvig Hricak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-07       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.